📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: IncellDx

1.1 - Company Overview

IncellDx Logo

IncellDx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular diagnostics focused on detecting and monitoring life-threatening viral diseases, offering HPV OncoTect 3Dx assay quantifying E6/E7 mRNA for cervical cancer; incellKINE Long COVID in vitro diagnostic (CE marked); HPV E6/E7 mRNA probe; CMV mRNA probe (RUO); hybridization core reagents; and HPV control cells (RUO).

Products and services

  • IncellKINE Long COVID In Vitro Diagnostic: CE-marked diagnostic test for Long COVID, delivering regulated detection of the condition per European conformity standards
  • HPV OncoTect 3Dx™: In vitro diagnostic assay that quantifies HPV E6 and E7 mRNA to detect and monitor cervical cancer via quantitative mRNA analysis
  • HPV E6, E7 mRNA Probe: Ready-to-use probe that detects HPV E6 and E7 mRNA, delivering specific mRNA detection for related assays

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to IncellDx

Adrenomed Logo

Adrenomed

HQ: Germany Website
  • Description: Provider of clinical-stage biopharmaceutical development focused on rescuing vascular integrity to save critically ill patients with limited treatment options, including the lead product candidate Adrecizumab, a first-in-class monoclonal antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adrenomed company profile →
PointCare Logo

PointCare

HQ: United States Website
  • Description: Provider of cellular analysis methods, inventing and developing methods in the field of cellular analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PointCare company profile →
Okairos Logo

Okairos

HQ: Switzerland Website
  • Description: Provider of biopharmaceutical discovery and development of genetic T-cell vaccines, including for hepatitis C virus, and health and allied services. Based in Basel, Switzerland, with operations in Rome and Naples, Italy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Okairos company profile →
DeepUll Logo

DeepUll

HQ: Spain Website
  • Description: Provider of a biotech diagnostic system for early-stage sepsis that rapidly identifies pathogens and delivers an antibiogram within hours, leveraging patient immunological and functional data.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DeepUll company profile →
Uvax Bio Logo

Uvax Bio

HQ: United States Website
  • Description: Provider of vaccine R&D leveraging patented protein nanoparticle technology via the 1c-SApNP platform for single-component, self-assembling nanoparticles that display antigens. Offers vaccine candidates for HIV-1 (UVAX-1107 and UVAX-1197; Phase 1), COVID-19 (Uvax-2129, designed to address multiple variants), Ebola virus, and hepatitis C virus (HCV).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Uvax Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for IncellDx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to IncellDx

2.2 - Growth funds investing in similar companies to IncellDx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for IncellDx

4.2 - Public trading comparable groups for IncellDx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to IncellDx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About IncellDx

What does IncellDx do?

IncellDx is a provider of molecular diagnostics focused on detecting and monitoring life-threatening viral diseases, offering HPV OncoTect 3Dx assay quantifying E6/E7 mRNA for cervical cancer; incellKINE Long COVID in vitro diagnostic (CE marked); HPV E6/E7 mRNA probe; CMV mRNA probe (RUO); hybridization core reagents; and HPV control cells (RUO).

Who are IncellDx's competitors?

IncellDx's competitors and similar companies include Adrenomed, PointCare, Okairos, DeepUll, and Uvax Bio.

Where is IncellDx headquartered?

IncellDx is headquartered in United States.

How many employees does IncellDx have?

IncellDx has 1,000 employees 🔒.

When was IncellDx founded?

IncellDx was founded in 2010 🔒.

What sector and industry vertical is IncellDx in?

IncellDx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for IncellDx

Who are the top strategic acquirers in IncellDx's sector and industry

Top strategic M&A buyers and acquirers in IncellDx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for IncellDx?

Top strategic M&A buyers groups and sectors for IncellDx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in IncellDx's sector and industry vertical

Which are the top PE firms investing in IncellDx's sector and industry vertical?

Top PE firms investing in IncellDx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in IncellDx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in IncellDx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in IncellDx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to IncellDx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in IncellDx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for IncellDx?

The key public trading comparables and valuation benchmarks for IncellDx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for IncellDx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for IncellDx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in IncellDx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for IncellDx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in IncellDx's' sector and industry vertical?

Access recent funding rounds and capital raises in IncellDx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for IncellDx